Celsius (NASDAQ:CELH) Price Target Cut to $45.00 by Analysts at UBS Group

Celsius (NASDAQ:CELH) had its price objective reduced by equities research analysts at UBS Group from $50.00 to $45.00 in a research report issued on Thursday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. UBS Group’s target price suggests a potential upside of 46.29% from the stock’s previous close.

Several other research analysts have also recently weighed in on CELH. Bank of America lowered their price objective on Celsius from $32.00 to $26.00 and set an “underperform” rating on the stock in a research report on Thursday, September 5th. Roth Mkm cut their price objective on shares of Celsius from $45.00 to $43.00 and set a “buy” rating for the company in a report on Friday, September 27th. Maxim Group decreased their target price on shares of Celsius from $65.00 to $50.00 and set a “buy” rating on the stock in a research report on Thursday, September 5th. Morgan Stanley reiterated an “equal weight” rating and issued a $50.00 price target on shares of Celsius in a research report on Tuesday, August 20th. Finally, Truist Financial increased their price target on Celsius from $30.00 to $35.00 and gave the stock a “hold” rating in a research report on Wednesday, October 16th. One research analyst has rated the stock with a sell rating, three have given a hold rating and eleven have assigned a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $54.80.

Celsius Price Performance

Celsius stock traded up $0.72 during trading hours on Thursday, hitting $30.76. The company had a trading volume of 2,726,462 shares, compared to its average volume of 5,916,661. Celsius has a one year low of $27.78 and a one year high of $99.62. The firm has a market cap of $7.17 billion, a PE ratio of 29.93, a PEG ratio of 2.43 and a beta of 1.86. The firm has a 50-day moving average of $32.49 and a 200 day moving average of $51.64.

Celsius (NASDAQ:CELH) last released its quarterly earnings results on Tuesday, August 6th. The company reported $0.28 earnings per share for the quarter, topping the consensus estimate of $0.23 by $0.05. The business had revenue of $402.00 million during the quarter, compared to analysts’ expectations of $391.07 million. Celsius had a return on equity of 94.75% and a net margin of 19.58%. The firm’s revenue for the quarter was up 23.4% compared to the same quarter last year. During the same period last year, the firm posted $0.17 EPS. As a group, research analysts expect that Celsius will post 0.79 earnings per share for the current year.

Insiders Place Their Bets

In other news, CEO John Fieldly sold 74,847 shares of the business’s stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $32.80, for a total transaction of $2,454,981.60. Following the sale, the chief executive officer now directly owns 1,812,490 shares in the company, valued at approximately $59,449,672. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 2.20% of the company’s stock.

Institutional Investors Weigh In On Celsius

A number of institutional investors have recently made changes to their positions in the stock. S.A. Mason LLC bought a new position in shares of Celsius during the second quarter worth about $30,000. EverSource Wealth Advisors LLC raised its holdings in Celsius by 3,116.7% during the 1st quarter. EverSource Wealth Advisors LLC now owns 386 shares of the company’s stock worth $32,000 after purchasing an additional 374 shares during the last quarter. Livforsakringsbolaget Skandia Omsesidigt acquired a new position in shares of Celsius in the 3rd quarter worth approximately $34,000. Signaturefd LLC lifted its position in shares of Celsius by 48.3% in the 3rd quarter. Signaturefd LLC now owns 1,160 shares of the company’s stock worth $36,000 after purchasing an additional 378 shares during the period. Finally, Benjamin F. Edwards & Company Inc. boosted its stake in shares of Celsius by 353.1% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 648 shares of the company’s stock valued at $37,000 after purchasing an additional 505 shares during the last quarter. Institutional investors own 60.95% of the company’s stock.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.